NHS England increases ARRS reimbursement for pharmacists in 2025/2026 The maximum reimbursable amount for Band 7–8a pharmacists employed under the Additional Roles Reimbursement Scheme will increase to £66,972.…
Community pharmacies in England could offer ‘catch-up’ HPV vaccinations Updated NHS plans to eliminate cervical cancer have suggested community pharmacy as a location for catch-up vaccinations to improve access to the HPV vaccine.…
NHS England seeking supplier for foundation course content The contract will run from 2025 when NHS England takes over responsibility for the foundation pharmacist training programme from the General Pharmaceutical Council.…
Medicines derived from UK blood plasma distributed to NHS hospitals for ‘first time in a generation’ More than 250,000 litres of plasma from UK donors have been sent to human protein product manufacturer Octapharma to produce NHS medicines for the first time since a 1998 ban.…
Pharmacists included in latest cohort of NIHR senior investigators The National Institute for Health and Care Research's senior investigators will receive discretionary funding of £20,000 per year of appointment to support research activities, “while they take on a senior leadership role within NIHR”.…
Pharmacists asked to assist in switching patients from Promixin by end of April 2025 A national patient safety alert advises that Colicym 1-million-unit power for nebuliser solution unit dose vials should be considered as an alternative treatment.…
UK medicines market ‘broken’ as levy on sales of branded medicines doubles, says ABPI The Department of Health and Social Care‘s proposals for the review of the statutory scheme for branded medicines would see a sharp increase in payments for the rest of the current year.…
Gail Caldwell receives RPS Charter Award The director of pharmacy at NHS Greater Glasgow and Clyde was given the award for being a “driving force” behind improvements to pharmacy service and workforce development in Scotland.…
NICE recommends first combination pill for long-term treatment of endometriosis Relugolix combination therapy is a second-line treatment option for endometriosis that is faster acting than injectable treatments and can be taken at home.…
UK chief pharmaceutical officers back RPS royal college proposals The four officers have “strongly encouraged” Society members to vote in favour of a Royal College of Pharmacy, as the ballot on the decision opens.…